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Aim of the work: To evaluate the role of volumetric MRI to identify a pattern of regional atrophy
characteristic in differentiation between Alzheimer’s disease, Mild Cognitive Impairment, and Nor-
mal elderly control.
Material and methods: The regional ethics committee approved the study and written informed
consent was obtained from all participants. Between April 2012 and May 2013, prospective study
was conducted on 25 patients (18 males and 7 females) and 15 healthy elderly controls (9 males and
6 females) referred to the Radiodiagnosis Department from the Neuropsychiatry Department that
had clinical manifestations of suspected cognitive impairment, we used the Mini Mental State
Examination (MMSE) as a measure of general cognitive function and the total learning from thee; NPV,
bability
.
Khalil),
oo.com
512 R. Elshafey et al.Auditory Verbal Total Learning Test (AVTOT) as a measure of memory performance. One year
follow up of patients was done to assess the disease progress.
Results: Twenty-ﬁve patients were included in this study {Alzheimer disease (10 cases), MCI (15
cases)} and 15 healthy elderly controls. Mean MMSE scores were signiﬁcantly lower in patients
with Alzheimer’s disease compared with MCI and control cases (P < 0.001). Positive correlation
(except left caudate nucleus) between gray matter volume reduction in MCI and AD in relation
to elderly control and MMSE score was observed. The Auditory Verbal Learning Test (AVTOT)
was signiﬁcantly lower in patients with Alzheimer’s disease compared with MCI and control cases
(P< 0.001). No signiﬁcant differences were found between groups as regards age, sex, education or
dominant hand. Signiﬁcant gray matter volume reductions were found in both AD and MCI com-
pared to healthy elderly control however no signiﬁcant differences were found among MCI patients
or AD patients. Sensitivity, speciﬁcity, PPV and NPV of caudate nucleus and hippocampal volume
reduction in AD and MCI in relation to elderly control were higher than entorhinal cortex.
Conclusion: Semi-automated MR volumetric measurements can be used to determine atrophy in
hippocampus, caudate nucleus and entorhinal cortex which aided in discrimination of healthy
elderly control subjects from subjects with AD and MCI and predict clinical decline of MCI leading
to increase the efﬁciency of clinical treatments, delay institutionalization and improve cognition and
behavioral symptoms.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Alzheimer disease (AD) is the most common cause of dementia
in the elderly with a progressive course, beginning with neuro-
nal dysfunction and irreversible loss of neurons, while MCI
can represent a transitional state between normal aging and
AD with the density and distribution of the tau-associated
neuroﬁbrillary and beta-associated amyloid for a long time be-
fore the clinical onset of AD (1).
Mild Cognitive Impairment (MCI) is associated with an in-
creased risk of progression to a diagnosis of probable Alzhei-
mer disease (AD). Rates of progression vary; some individuals
with MCI deteriorate rapidly, others remain stable for many
years, and some revert to normal cognitive status. Improved
ability to predict risk of imminent decline in patients with
MCI could aid in the efﬁciency of large scale clinical trials
and will become increasingly important for individual patient
risk stratiﬁcation as aggressive new treatments are developed
(2).
Magnetic resonance imaging (MRI) is a reliable supportive
tool for the diagnosis of dementia and can reveal cortical atro-
phy, sulcal and ventricular dilatation, decreased parenchymal
and hippocampal volume and changes in parenchymal inten-
sity (2,3).
Investigators in recent studies have reported that the brain
volumes derived from magnetic resonance (MR) images, par-
ticularly those obtained in the temporal and parietal lobes, en-
able accurate differentiation between individuals with Mild
Cognitive Impairment (MCI) and probable AD and those
who are cognitively healthy (4,5). In addition, brain volumes
and cortical thicknesses have been shown to be predictive of
which individuals with MCI will eventually develop AD. All
of these studies, however, involved analyses focused on the
medial temporal lobe and the use of semiautomated or manual
delineation of volumes (6–8).
Volumetric measurements of the medial temporal lobe have
been shown to reveal a typical sign of AD (9–13). The hippo-
campus is the most extensively studied structure in ADreaching correct classiﬁcation rates of 88.14% by discriminant
function analysis of AD patients and controls (14).
Thus, the purpose of our study was to evaluate the role of
volumetric MRI to identify a pattern of regional gray matter
atrophy characteristic in differentiation between Alzheimer’s
disease, Mild Cognitive Impairment, and Normal elderly
control.
2. Patients and methods
Approval of Research Ethics Committee (REC) of Tanta Uni-
versity and informed written consent were obtained from all
participants in the study.
From April 2012 to May 2013, 25 patients were included in
this study {10 patients with Alzheimer disease (7 men, 3 wo-
men; mean age ± [SD], 73 years ± 6), 15 patients with MCI
(11 men, 4 women; mean age ± SD,71 years ± 5)}, 15 control
subjects with normal healthy aging who were conﬁrmed to be
healthy by neuropsychological tests (9 men, 6 women; mean
age ± SD, 68 years ± 6), those patients were referred to the
Radiodiagnosis Department from wards and clinics of the neu-
ropsychiatry department that have clinical manifestations of
suspected cognitive impairment. We used Mini Mental State
Examination (MMSE) (15) as a measure of general cognitive
function and the total learning from the Auditory Verbal
Learning Test (AVTOT) (16) as a measure of memory
performance.
Total learning from the Auditory Verbal Learning Test
(AVTOT) (16) was selected as the measure of memory perfor-
mance which has a list of 15 words, which an examiner reads
aloud at the rate of one per second. The patient’s task is to re-
peat all the words he or she can remember, in any order. This
procedure is carried out for a total of ﬁve times.
All individuals of the study were subjected to: full history
taking, thorough clinical examination and routine laboratory
investigations in the form of: CBC, liver and kidney function
test, fasting and 2 h postprandial blood glucose, ESR, LDH,
CRP with 1 year follow up for all the patients.
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The images were acquired by using a 1.5-T General Electric
scanner (GE Medical Systems, Milwaukee) with quadrature
head coil (8 channel).
Sedation was needed for 10 patients (for uncooperative pa-
tients and abnormal movements).
Inclusion criteria were patients who had clinical manifesta-
tions of suspected cognitive impairment using the Mini Mental
State Examination (MMSE) and the Auditory Verbal Learn-
ing Test (AVTOT).
12 patients were excluded from this study as they had
causes of dementia other than Alzheimer’s disease (cerebrovas-
cular disease (5cases), brain tumors (2 cases), hepatic enceph-
alopathy (3 cases), renal failure (2 cases)).
A three-dimensional Fourier transform spoiled gradient-re-
called acquisition sequence was used that resulted in a coronal
series of contiguous 1.5-mm images throughout the brain per-
pendicular to the anterior commissure–posterior commissure
line and averaged after off-line motion correction. Standard
neuroanatomical landmarks (such as the orbits, sulci and the
commissures) were used to correct possible deviations in any
of the orthogonal planes. The following parameters used
for the spoiled gradient-recalled images were: echo time
(TE) = 3 ms, repetition time (TR) = 25 ms, repetition = 1,
nutation angle = 45, ﬁeld of view= 24 cm, acquisition matrix =
256 · 256 · 124, voxel dimensions = 0.9375 · 0.9375 · 3 mm,
and resolution 1 · 1 · 1 mm. Fast ﬂuid-attenuated inversion
recovery ([TR/TE/NEX] 8000/142/1; inversion time, 2200 ms)
and diffusion weighted images (Diffusion-weighted imaging
was single-shot spin-echo echo-planar (([TR/TE/NEX]
10,000/93)) with diffusion sensitivities of b= 0 s/mm2 and
b= 1000 s/mm2 were obtained to exclude cerebrovascular
disease.
This protocol resulted in high-spatial-resolution images
with excellent gray-white matter contrast, and it was used for
measuring by means of manual tracing of speciﬁc gray matter
(hippocampus, caudate and entorhinal cortex) regions of
interest.
Volumetric analysis of the hippocampus, caudate nucleus
and entorhinal cortex was performed using 3D Slicer version
4.2.2-1 software which is a multiplatform, free open source
software package for visualization and medical image comput-
ing developed by the Harvard university and approved for
medical research (http://www.slicer.org/) on workstation with
software (Functool, GE Healthcare, Milwaukee, WI, USA).
The nuclei’ subject of study was segmented in a semi-auto-
matic way by tracing their outlines manually, and the software
was preset not to exceed the outlines of the region of interest
by assigning the MR numbers of the tissue subject of study.
After each of the slice of the brain with the nuclei or regions
of interest was segmented, a quantiﬁcation process was run
which rendered the volume of the structure in focus as well
as a three dimensional graphical model of it.
Segmentation was performed by four trainee physicians (in-
terns) who had an adequate background of using different
graphics software after teaching them a course of MRI anat-
omy of the brain and allowing them to test with several normal
cases before turning to the subjects of the study. They reached
their results with no knowledge of the primary MMSE or Ver-
bal Learning Test score; they reached a consensus opinion(with insigniﬁcant interobserver variation (P= 1.93) before
reviewing the results of each other or the patient’s scores.
The segmentation process was further revised by two Radiol-
ogistswith amore than 15 years of experience inNeuroradiology,
minor modiﬁcations of the segmentation process were applied
when deemed necessary. The data is validated by comparison
with SPL-PNL Brain Atlas Developed by Talos et al. (17).
2.2. MRI data preprocessing
Semiautomatic methods provide a more realistic approach for
gray matter segmentation because they combine the automatic
techniques with a priori operator knowledge of the gray matter
location, anatomical boundaries, and shape.
2.3. Measurement of the hippocampal volume ROI analysis
Tracing of the hippocampus started rostrally where the hippo-
campus ﬁrst appears below the amygdala and ended posteri-
orly in the section where the crura of the fornices depart
from the lateral wall of the lateral ventricles. The hippocampus
included the dentate gyrus, the hippocampus proper and the
subicular complex (18,19). Each hippocampus was traced inde-
pendently with a reference to the previous hippocampal MR
volumetric studies (20,21) and the hippocampal atlas by
Duvernoy (22).
2.3.1. Caudate nucleus ROI
The caudate was divided into three parts, head, body and tail,
which were traced separately. Tracing of the head of the cau-
date began in the ﬁrst slice in which the internal capsule clearly
separated the caudate from the putamen and in which the cav-
ity of the lateral ventricle was visible, all portions of the cau-
date nucleus were included until the tail curved ventrally to
border the lateral atrium of the lateral ventricles (23).
2.4. The entorhinal cortex ROI
EC was measured from the level, where the ambiens gyrus, the
amygdala and the white matter of the parahippocampal gyrus
were ﬁrst visible to the section preceding the lateral geniculate
nucleus (24).
Statistical presentation and analysis of the present study
were conducted, using the mean and standard deviation by
SPSS V.16. Analysis of variance [ANOVA] tests and Tukey’s
test was used to determine the signiﬁcance between two
groups: according to the computer program SPSS for Win-
dows. ANOVA test was used for comparison among different
times in the same group in quantitative data. P value <0.05
was considered signiﬁcant.
3. Results
25 patients were included in this study {10 patients with Alz-
heimer disease (7 men, 3 women; mean age ± [SD],
73 years ± 6), 15 patients with MCI (11 men, 4 women; mean
age ± SD,71 years ± 5)}, 15 control subjects with normal
healthy aging who were conﬁrmed to be healthy by neuropsy-
chological tests (9 men, 6 women; mean age ± SD,
68 years ± 6).
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and Alzheimer disease cases are shown in Table 1.
Mean MMSE scores were signiﬁcantly lower in patients
with Alzheimer’s disease compared with MCI and control
cases (P < 0.001) (Table 1). Also there is positive correlation
(apart from left caudate nucleus) between gray matter volume
reduction in MCI and AD in relation to elderly control and
MMSE score after a 1-year follow-up (Table 2).
The Auditory Verbal Learning Test (AVTOT) was also sig-
niﬁcantly lower in patients with Alzheimer’s disease compared
with MCI and healthy elderly control cases (P < 0.001)
(Table 1).
There were no signiﬁcant correlation between-group differ-
ences in age, sex, education or dominant hand.
Negative correlation was between age of patients and gray
matter volume reduction which means that increasing the age
matched with more reduction in gray matter volume (r (Corre-
lation Coefﬁcient) was 0.171, 0.478, 0.608 for hippocam-
pus, caudate and entorhinal cortex volumes).
Signiﬁcant gray matter volume reductions ((hippocampus,
caudate nucleus and entorhinal cortex) were found in AD than
MCI compared to healthy elderly control. (Table 3) (Figs. 1
and 2).
However no signiﬁcant differences were found among MCI
patients or AD patients (P= 1.46).
No signiﬁcant correlations were found between the right
and left sides (P= 0.76).
Sensitivity, speciﬁcity, PPV and NPV of caudate nucleus
and hippocampal volume reduction in AD and MCI in
relation to healthy elderly control were higher than entorhinalTable 1 Demographic data and cognitive score.
Group Normal control
Number Male 15 9
Female 6
Mean age + SD 68 years ± 6 71 years ± 5
Dominant hand Right 13 12
Left 2 3
Educational (years)
8 3 4
12 8 9
16 4 2
MMSE score (0–30 points) 28.4 ± 1.3 24.6 ± 2.5
Verbal learning test score (0–15) 10.8 ± 2.5 5.2 ± 2.4
Table 2 Correlation between gray matter volume at different site
among the studied patients and the control group.
Volume of gray matter
at diﬀerent sites (cm3)
MMSE total scores of the study subjects
Patients with AD (n= 10) Pa
r P R
Right caudate 0.149 0.048* 0
Left caudate 0.052 0.082 0
Right hippocampus 0.340 0.037* 0
Left hippocampus 0.375 0.042* 0
R. entorhinal cortex 0.318 0.035* 0
L. entorhinal cortex 0.404 0.077 0
r=Correlation coefﬁcient.
* Signiﬁcant (P< 0.05).cortex, and the sensitivity of the study is increased by combi-
nation between gray matter volumes and MMSE score
(Table 4).
4. Discussion
Alzheimer disease (AD) is the most common cause of dementia
in the elderly with a progressive course, beginning with neuro-
nal dysfunction and irreversible loss of neurons, while MCI
can represent a transitional state between normal aging and
AD with the density and distribution of the tau-associated
neuroﬁbrillary and beta-associated amyloid for long time be-
fore the clinical onset of AD (1).
Our study was designed to identify a pattern of regional
atrophy characteristic aiming in differentiation between Alz-
heimer’s disease, Mild Cognitive Impairment, and Normal el-
derly control for early effective treatment of MCI.
The probable strength of our study in relation to previous
studies focusing in examining hippocampal volume in differen-
tiating MCI from AD and normal changes of aging is the com-
bination between caudate nucleus, entorhinal cortex and
hippocampal volumes in differentiation. This may result in in-
creased results’ accuracy because hippocampal atrophy is also
seen with parkinsonism, schizophrenia, alcoholism, and other
forms of dementia (24–26). This also more accurate than re-
sults using caudate nucleus alone as it can be atrophied in
other diseases as Huntington’s disease (27).
Hippocampal volume was signiﬁcantly smaller in patients
with Mild Cognitive Impairment than in controls in the pres-
ent study, a ﬁnding consistent with other reports (8,9,28). ThisMCD Alzheimer P value Signiﬁcance
15 11 10 7 0.08 Ns
4 3 0.07 Ns
73 years ± 6 0.07 Ns
9 0.09 Ns
1 0.14 Ns
2 0.27 Ns
5
3
11.6 ± 4.2 <0.001 S
3.2 ± 1.9 <0.001 S
s and total scores of Mini Mental State Examination (MMSE)
tients with MCI (n= 15) Control group (n= 15)
P r P
.123 0.026* 0.139 0.028*
.092 0.055 0.104 0.049*
.29 0.039* 0.245 0.045*
.28 0.05* 0.122 0.077
.35 0.052 0.390 0.026*
.47 0.041* 0.431 0.021*
Fig. 1 Healthy elderly control subject with normal cognitive function T1-weighted 3 D spoiled gradient magnetic resonance images. (a)
Coronal images through the right hippocampus (volume equal 2.21 cm3). (b) Axial images through right caudate nucleus (volume equal
3.87 cm3). (c) Coronal images through the right entorhinal cortex (volume equal 1.92 cm3).
Table 3 Gray matter MR volumetric measurements in the control group, MCI and AD in different sites.
Volume of gray matter
at diﬀerent sites (cm3)
Patients with alzheimer disease (n= 10) Patients with MCI (n= 15) Control cases t-Test P
Range Mean ± SD Range Mean ± SD Range Mean ± SD
Right caudate 2.29–3.23 2.94 ± 0.35 3.30–3.81 3.47 ± 0.25 3.84–4.03 3.67 ± 0.27 5.877 0.0566
Left caudate 1.97–3.12 2.58 ± 0.32 2.90–3.41 3.28 ± 0.27 3.64–3.95 3.61 ± 0.22 10.172 0.0001*
Right hippocampus 1.02–2.29 1.67 ± 0.44 1.32–2.34 1.72 + 0.34 1.42–2.53 1.86 ± 0.29 0.581 0.001*
Left hippocampus 1.02–2.23 1.57 ± 0.40 1.3–2.31 1.7 + 0.31 1.39–2.63 1.98 ± 0.32 2.736 0.002*
R. entorhinal cortex 1.12–1.32 1.24 ± 0.09 1.28–1.65 1.39 ± 0.19 1.72–2.04 1.78 ± 0.18 1.119 0.027*
L. entorhinal cortex 1.08–1.27 1.18 ± 0.13 1.18–1.62 1.28 ± 0.16 1.62–2.01 1.77 ± 0.16 1.555 0.013*
*
Signiﬁcant difference.
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and to predict more rapid deterioration to clinical Alzheimer’s
disease for early effective treatment.In our study there is no signiﬁcant difference between right
and left hippocampus (P 0.76) this is inconsistent with the
result of Slavin et al. 2007 (29) that they found that left
Fig. 2 Patient with AD. T1-weighted 3D spoiled gradient magnetic resonance images. (a) Coronal images through the right
hippocampus (volume equal 1.43 cm3). (b) Axial images through right caudate nucleus (volume equal 2.52 cm3). (c) Coronal images
through the right entorhinal cortex (volume equal 1.25 cm3).
Table 4 Sensitivity, speciﬁcity, PPV and NPP of MR volumetric measurements of different gray matter structures in differentiation
between normal aging, MCI and AD.
Gray matter volume Sensitivity Speciﬁcity PPV NPV
Hippocampus 95.86 97.63 98.52 97.52
Caudate nucleus 95.32 92.57 88.25 85.90
Entorhinal cortex 93.3 89.63 87.40 88.90
Combination between gray matter structures 96.36 98.41 99.63 97.52
Combination between gray matter volumes and MMSE score 100% 92.30% 98.86% 100%
516 R. Elshafey et al.hippocampal volume had more discriminatory value than right
hippocampal volume.
Combination of gray matter structures’ volume and MMSE
score increase the sensitivity and speciﬁcity for discrimination
between AD, Mild Cognitive Impairment from the normalchanges of aging this is consistent with the result of Slavin
et al. 2007 (29).
Our results reveal that sensitivity, speciﬁcity, PPV and NPV
of caudate nucleus and hippocampal volume reduction in AD
and MCI in relation to healthy elderly control were higher
Hippocampus, caudate nucleus and entorhinal cortex volumetric MRI measurements 517than entorhinal cortex this agree with the result of Madsen
et al. (27) as they conclude that caudate effect sizes, while sig-
niﬁcant, were generally lower than those for the ventricles and
hippocampus, but our results disagree with Kantarci et al.
2005 (14) as their results reveal equal accuracy of hippocampal
volumes and entorhinal cortex measures.
The current study reveals positive correlation between gray
matter volume reduction in MCI and AD in relation to elderly
control and MMSE score after a 1-year follow-up in the MCI
group, these association is in accordance with Madsen et al.
2010 (27) whereas these associations were not detectable in
the study of hippocampal atrophy (Morra et al. 2009b) (26).
There are no signiﬁcant differences of gray matter volumes
as regards gender (male and female) p= 0.8 and 0.7, respec-
tively. These ﬁndings are consistent with the previous study
by Dolek et al. 2012 (24).
Limitation of this study is the time consuming protocol of
MR volumetry, relatively short time follow up of patients, also
relatively low number of cases decrease the power of statistical
analysis. Larger sample size and longitudinal study are needed
to conﬁrm our ﬁndings.
5. Conclusion
Semi-automated MR volumetric measurements can be used to
determine atrophy in hippocampus, caudate nucleus and
entorhinal cortex which aided in discrimination of healthy el-
derly control subjects from subjects with AD and MCI and
predict clinical decline of MCI leading to increase the efﬁ-
ciency of clinical treatments and delay institutionalization
and improve cognition and behavioral symptoms.
Conﬂict of interest
None.
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